Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer
Status:
Completed
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
This is a study for patients with resectable, locally advanced esophageal cancer. There is
evidence to suggest that celecoxib in combination with cisplatin and irinotecan (CPT-11) may
work well with radiation therapy to kill cancer cells. The primary goal is to develop a
well-tolerated cancer treatment that has an acceptable response rate.
Phase:
Phase 2
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Brigham and Women's Hospital Massachusetts General Hospital Pharmacia